| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |